General contact

Head Office
Novartis International AG
CH-4002 Basel
Switzerland

+41 61 324 11 11
+41 61 324 80 01
Monday - Friday,
8:30 - 17:00, GMT+1
(Central European Time)

Investors

Novartis International AG
Investor Relations
P.O. Box
CH-4002 Basel
Switzerland

+41 61 324 79 44

Media

Global Media Relations
Eric Althoff
Basel, Switzerland

+41 61 324 7999

pane 4 content

Pharmaceuticals

Innovating to treat disease more effectively

Our global Pharmaceuticals portfolio includes more than 60 key marketed products, many of which are innovative leaders in their therapeutic areas. In 2010 we received a total of 13 major approvals and made 16 regulatory submissions in the United States, Europe and Japan.

Learn more about our Pharmaceuticals Division

Learn more about Novartis pharmaceuticals in your country:

Key pharmaceutical products marketed by Novartis are listed below by therapeutic area.

  • Cardiovascular and Metabolism

    Amturnide (aliskiren, amlodipine and hydrochlorothiazide)

    Diovan (valsartan)

    Diovan HCT/Co-Diovan (valsartan and hydrochlorothiazide)

    Eucreas (vildagliptin and metformin)

    Exforge (valsartan and amlodipine besylate)

    Exforge HCT (valsartan, amlodipine besylate and hydrochlorothiazide)

    Galvus (vildagliptin)

    Lescol/Lescol XL (fluvastatin sodium)

    Lotensin/Cibacen (benazepril hydrochloride)

    Lotensin HCT/Cibadrex (benazepril hydrochloride and hydrochlorothiazide)

    Lotrel (amlodipine besylate and benazepril hydrochloride)

    Rasilamlo (aliskiren and amlodipine), available in the European Union

    Starlix (nateglinide)

    Tekamlo (aliskiren and amlodipine)

    Tekturna/Rasilez (aliskiren)

    Tekturna HCT/Rasilez HCT(aliskiren and hydrochlorothiazide)

    Valturna (aliskiren and valsartan)

  • Oncology

    Afinitor (everolimus)

    Exjade (deferasirox)

    Femara (letrozole tablets/letrozole)

    Gleevec/Glivec (imatinib mesylate/imatinib)

    Proleukin (aldesleukin)

    Sandostatin LAR & Sandostatin SC (octreotide/IM injection)

    Tasigna (nilotinib)

    Zometa (zoledronic acid)

  • Neuroscience and Ophthalmics

    Clozaril/Leponex (clozapine)

    Comtan (entacapone)

    Exelon & Exelon Patch (rivastigmine tartrate & rivastigmine transdermal system)

    Extavia (interferon beta-1b)

    Fanapt (iloperidone)

    Focalin & Focalin XR (dexmethylphenidate HCl & dexmethylphenidate modified release)

    Gilenya (fingolimod)

    Ritalin & Ritalin LA (methylphenidate HCl & methylphenidate HCl modified release)

    Lucentis (ranibizumab)

    Stalevo (carbidopa, levodopa and entacapone)

    Tegretol (carbamazepine)

    Trileptal (oxcarbazepine)

    Visudyne (verteporfin)

  • Respiratory

    Foradil (formoterol)

    Onbrez Breezhaler/Arcapta Neohaler (indacaterol)

    TOBI (tobramycin)

    Xolair (omalizumab)

  • Integrated Hospital Care

    Zortress/Certican (everolimus)

    Cubicin (daptomycin)

    Ilaris (canakinumab)

    Myfortic (mycophenolic acid/mycophenolate sodium, USP)

    Neoral (cyclosporine, USP Modified)

    Simulect (basiliximab)

    Tyzeka/Sebivo (telbivudine)

  • Other

    Reclast/Aclasta (zoledronic acid/zoledronic acid 5 mg)

    Coartem/Riamet (artemether and lumefantrine)

    Combipatch/Estalis/Estalis Sequi (estradiol hemihydrate and norethisterone acetate)

    Estraderm TTS/Estraderm MX (estradiol hemihydrate)

    Estragest TTS Sequidot (estradiol hemihydrate and norethisterone acetate)

    Famvir (famciclovir)

    Lamisil (terbinafine)

    Miacalcin/Miacalcic (salmon calcitonin)

    Vivelle Dot/Estradot (estradiol hemihydrate)

    Voltaren/Cataflam (diclofenac sodium/potassium)